New Series of Executive Management Briefings on Email Strategy Begins Friday 20 March

LONDON - ATTN: Feature Editors

- With Photo

Award winning email service provider Database Group Interactive will
provide a new series of Executive Briefings and Seminars on the topics of
email strategy, multichannel marketing, and data insight. The first session
on Friday 20 March will focus on Strategic Planning and will present new
benchmark findings of customer response trends across various economic
sectors.

ZSL Launches Mobile and Business Power Add-Ons to Extend Microsoft Dynamics CRM, GP and NAV for Windows Mobile, Blackberry, iPhone and Android Mobile Devices

NEW ORLEANS - ZSL, a leading ISV & Global Software Solutions and Services provider,
launches “Mobile Power”
(www.zslinc.com/MS-Dynamics-CRM-Add-on-Solutions.html) and “Business
Power” (www.zslinc.com/MS-Dynamics-CRM-Add-on-Solutions.html), a suite
of add-ons for Microsoft Dynamics CRM, GP and NAV.

Chiquita Sets Annual Meeting Date of May 20, 2009

CINCINNATI - Chiquita Brands International, Inc. (NYSE: CQB) announced today that it
will hold its Annual Meeting of Shareholders on May 20, 2009, on the 28th
floor of the Chiquita Center at 250 East Fifth Street, Cincinnati. The record
date for determining shareholders entitled to vote at the meeting will be
March 23, 2009. In mid-April, the company will mail to shareholders of record
a notice of the meeting and information about accessing the proxy materials
online or obtaining paper copies.

Further 100 Million Euros Allocated to Netherlands-Based R&D Targeting the Early Diagnosis and Treatment of Disease

EINDHOVEN, The Netherlands - The Center for Translational Molecular Medicine (CTMM) - the Dutch
public-private partnership committed to the research and development of new
techniques for the diagnosis and treatment of major diseases - today
announced that eight new research projects will receive funding from the
CTMM. It means that almost 250 million Euros have now been allocated to
Netherlands-based translational projects that could radically improve patient
outcomes for diseases such as Alzheimer’s, rheumatoid arthritis, sepsis,
cardiovascular disorders and the most important forms of cancer.

Protected by Comment Guard Pro